PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Pharmacist-Led Reviews and Automated Algorithms Cut Inappropriate Medications

★ Editor's Pickdeprescribingpotentially inappropriate medicationspolypharmacyolder adultsprimary carepharmacist-led medication reviewclinical decision supportsystematic reviewgeriatricsSTOPP/STARTBeers Criteria Geriatrics

Background Information

Automated and pharmacist-led deprescribing curbs unsafe drug use in seniors.

Deprescribing is critical in managing polypharmacy and reducing the risks associated with potentially inappropriate medications (PIMs) in older adults. Automated algorithms and pharmacist-led interventions significantly reduced PIMs, while multidisciplinary approaches and educational activities had mixed results. No intervention significantly impacted mortality. Pharmacist-led and automated interventions may be effective tools in primary health care settings to minimize inappropriate medication use among older adults. Standardizing outcomes is necessary for future research. Pharmacist-led and automated interventions can reduce inappropriate medication use in older adults.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Oliveira EM, Ferreira LC, Silva MC, Hattori WT

Citation: Oliveira EM, Ferreira LC, Silva MC, et al. Optimizing Medication Use in Older Adults in Primary Care: A Systematic Review of the Effectiveness of Deprescribing Interventions. Geriatrics & gerontology international. 2026;26(7):e70677. doi:10.1111/ggi.70677

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.